Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7%

Published on 20/07/2023 at 08:03 - Modified on 20/07/2023 at 08:04

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical Holdings Limited Announces Board and Committee Changes, Effective 10 April 2025	10/04	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	26/03	CI
Zhongzhi Pharmaceutical Expects Profit to Plunge 45% in 2024	17/01	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2024	17/01	CI
Zhongzhi Pharmaceutical Invests in US Biotech Firm to Advance Alzheimer's Treatment	24/12	MT
Zhongzhi Pharmaceutical Holdings Plans to Unwind Contractual Agreements to Directly Hold Control Over Subsidiary	06/12	MT
Zhongzhi Pharmaceutical Holdings Limited Announces Resignation of Peng Zhiyun as Non-Executive Director	09/24/09	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	23/24/23	CI
Zhongzhi Pharmaceutical Warns of 40% Drop in H1 Profit	12/24/12	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2024	12/24/12	CI
Zhongzhi Pharmaceutical's Attributable Jumps in 2023	25/24/25	MT
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	22/24/22	CI
Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit	26/24/26	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	25/24/25	CI
Zhongzhi Pharmaceutical’s Profit Up 75% in H1	24/23/24	MT
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7%	20/23/20	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023	19/23/19	CI
Zhongzhi Pharmaceutical Unit Chooses Builder for New Factory	23/23/23	MT
Zhongshan Hengsheng Enters into the Construction Contract with Shenzhen Xinmei	23/23/23	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Zhongzhi Pharmaceutical Sees Twofold Jump in FY22 Profit	18/23/18	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022	18/23/18	CI
Zhongzhi Pharmaceutical Clocks Nearly 16% Jump in H1 Profit	26/22/26	MT
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI